Paula Greter: Access and Innovation in Hemophilia through ERAH2026
Paula Greter, Commercial Strategy and Market Access Director at Roche Brazil, shared a post on LinkedIn:
”Participating in ERAH2026 truly reinforced what drives me at Roche Farma Brasil: our purpose to transform science into hope and meaningful quality of life for families.
This is an unyielding pursuit of solutions that challenge the impossible.
In our long-term journey with the community, hemophilia remains a core priority, keeping us dedicated to securing two essential pillars: access and innovation.
To drive the future forward , we continually invest in developing next-generation approaches.
Alongside this, we take great pride in our humanitarian aid program in partnership with the WFH, bringing access to communities in over 30 countries.
Our commitment is continuous: ensuring that these patients’ lives keep moving forward, always.
Let’s keep this momentum alive.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session